1-4 of 4
Callum M. Sloss
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1841: IMGC936, an investigational ADAM9-targeting antibody drug conjugate, is active against patient-derived ADAM9-expressing xenograft models

Olga Ab, Juniper A. Scribner, Kerstin Sinkevicius, Deryk Loo, Stuart W. Hicks, Krystal Watkins, Francine Z. Chen, Christopher Espelin, Marian Themeles, Ying Li, Chet Bohac, Patrick Zweidler McKay, Paul A. Moore, Callum M. Sloss, Ezio Bonvini, Eric H. Westin
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1841.
https://doi.org/10.1158/1538-7445.AM2021-1841
Published: 01 July 2021
View article titled, Abstract 1841: IMGC936, an investigational ADAM9-targeting antibody drug conjugate, is active against patient-derived ADAM9-expressing xenograft models
Journal Articles

Abstract 1073: Increased internalization and processing of the CD37-targeting antibody-drug conjugate, naratuximab emtansine (IMGN529), in the presence of rituximab leads to enhanced potency in diffuse large B-cell lymphoma models

Stuart W. Hicks, Katharine C. Lai, Yong Yi, Prerak Shah, Cristina L. Gavrilescu, Joe Ponte, Callum M. Sloss, Angela Romanelli
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1073.
https://doi.org/10.1158/1538-7445.AM2017-1073
Published: 01 July 2017
View article titled, Abstract 1073: Increased internalization and processing of the CD37-targeting antibody-drug conjugate, naratuximab emtansine (IMGN529), in the presence of rituximab leads to enhanced potency in diffuse large B-cell lymphoma models
Journal Articles

Abstract 2129: HB-EGF expression in gastric cancer promotes chemotherapy resistance and represents a promising target for molecular therapy and a novel biomarker of 5-FU resistance

Juan A. Santamaria-Barria, Callum M. Sloss, James C. Cusack
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2129.
https://doi.org/10.1158/1538-7445.AM2011-2129
Published: 15 April 2011
View article titled, Abstract 2129: HB-EGF expression in gastric cancer promotes chemotherapy resistance and represents a promising target for molecular therapy and a novel biomarker of 5-FU resistance
Journal Articles

Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

Andrea Boni, Alexandria P. Cogdill, Ping Dang, Durga Udayakumar, Ching-Ni Jenny Njauw, Callum M. Sloss, Cristina R. Ferrone, Keith T. Flaherty, Donald P. Lawrence, David E. Fisher, Hensin Tsao, Jennifer A. Wargo
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5213–5219.
https://doi.org/10.1158/0008-5472.CAN-10-0118
Published: 30 June 2010
View article titled, Selective BRAF<sup>V600E</sup> Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
Open the PDF for Selective BRAF<sup>V600E</sup> Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function in another window
Includes: Supplementary data